Ignite Creation Date:
2024-10-25 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06543264
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-04
Brief Title:
Efficacy of Cryotherapy in Managing Chemotherapy-Induced Peripheral Neuropathy in Children With Leukemia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy of Cryotherapy in Managing Chemotherapy-Induced Peripheral Neuropathy in Children With Leukemia
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aimed to assess the efficacy of cryotherapy in controlling Peripheral Neuropathy in cancer children
Detailed Description:
Peripheral neuropathy is a serious condition characterized by symmetrical distal damage to the peripheral nerves that may be caused by several classes of drugs including chemotherapeutic agents Chemotherapy-induced peripheral neuropathy CIPN is an adverse effect estimated to occur in up to 40 of patients undergoing chemotherapy with its incidence increasing in patients being treated with multiple agents Pharmacists play a pivotal role in the prevention and management of CIPN by recommending evidence-based pharmacologic and non pharmacologic strategies appropriate for the individual patientPeripheral neuropathy PN is a systemic disease characterized by symmetrical distal damage to the peripheral nerves that negatively impacts patient quality of life QOL Prolonged symptoms associated with PN can cause pain interfere with functional ability eg dressing driving house-work and disrupt emotional health
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None